Swipe om te navigeren naar een ander artikel
The online version of this article (https://doi.org/10.1007/s11136-018-1910-8) contains supplementary material, which is available to authorized users.
Allergic rhinitis and asthma symptoms are detrimental to health-related quality of life (HRQoL). Health technology appraisal agencies often require cost–utility analysis when assessing new interventions. Appropriate utility estimates, which quantify the value of different conditions in cost–utility analyses, are scarce for allergic rhinitis and asthma health states. This study aimed to generate utilities for allergic rhinitis and asthma health states from a European general population sample of adults and children.
Health state descriptions incorporating symptoms, impact of symptoms on daily life and symptom treatment were developed using clinical guidelines. Descriptions were amended with clinician and patient input, and incorporated into a survey in which each health state was followed by a standard gamble (adults) or visual analogue scale (children) item. The survey was distributed to samples of adults and children aged 8 to 11 from four European countries that were stratified to represent the general population within that country.
1454 adults and 1082 children completed the survey. Mean health utilities ranged from 0.635 to 0.880 and those elicited in children were lower (0.635 to 0.705) than those elicited in adults (0.812 to 0.880). Disutilities assessing the impact of increased allergic rhinitis severity and comorbidities were also greater in children than in adults.
Symptoms of allergic rhinitis and asthma were valued as having a clinically meaningful impact on HRQoL. Children valued health states as poorer than adults, and further research should investigate whether this reflects true preferential differences or results from methodological and/or comprehension differences between the two groups.
NHS Choices. Allergic rhinitis. Available from: https://www.nhs.uk/conditions/allergic-rhinitis/.
NHS Choices. Asthma. Last updated 12/09/2016. Available from: https://www.nhs.uk/conditions/asthma/.
Feng, C. H., Miller, M. D., & Simon, R. A. (2012). The united allergic airway: Connections between allergic rhinitis, asthma, and chronic sinusitis. American Journal of Rhinology & Allergy, 26(3), 187. CrossRef
Disutility. York: York Health Economics Consortium (2016). Available from: http://www.yhec.co.uk/glossary/disutility/.
Allergic Rhinitis and its impact on Asthma (ARIA) (2007). Available from: http://www.whiar.org.
Global Initiative of Asthma (GINA) (2016). Available from: http://www.ginasthma.org.
Poole, C. D., Bannister, C. A., Andreasen, J. N., Andersen, J. S., & Currie, C. J. (2014). Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy. Health and Quality of Life Outcomes, 12(1), 99. CrossRefPubMedPubMedCentral
- Utility elicitation in adults and children for allergic rhinoconjunctivitis and associated health states
Tobias Sydendal Grand
Mercedes Romano Rodriguez
- Springer International Publishing